CORT vs. AMPH
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Amphastar Pharmaceuticals, Inc. (AMPH).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or AMPH.
Key characteristics
| CORT | AMPH | |
|---|---|---|
| YTD Return | 22.26% | -21.36% |
| 1Y Return | 22.87% | 5.21% |
| 3Y Return (Ann) | 24.75% | 38.52% |
| 5Y Return (Ann) | 23.73% | 18.39% |
| 10Y Return (Ann) | 30.31% | 15.78% |
| Sharpe Ratio | 0.34 | 0.15 |
| Daily Std Dev | 55.31% | 40.71% |
| Max Drawdown | -94.28% | -49.92% |
| Current Drawdown | 0.00% | -25.17% |
Fundamentals
| CORT | AMPH | |
|---|---|---|
| Market Cap | $4.15B | $2.37B |
| EPS | $1.13 | $3.15 |
| PE Ratio | 35.14 | 15.36 |
| PEG Ratio | 0.61 | 2.77 |
| Total Revenue (TTM) | $569.61M | $712.89M |
| Gross Profit (TTM) | $561.03M | $381.31M |
| EBITDA (TTM) | $129.11M | $271.78M |
Correlation
The correlation between CORT and AMPH is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CORT vs. AMPH - Performance Comparison
In the year-to-date period, CORT achieves a 22.26% return, which is significantly higher than AMPH's -21.36% return. Over the past 10 years, CORT has outperformed AMPH with an annualized return of 30.31%, while AMPH has yielded a comparatively lower 15.78% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. AMPH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CORT vs. AMPH - Dividend Comparison
Neither CORT nor AMPH has paid dividends to shareholders.
Drawdowns
CORT vs. AMPH - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than AMPH's maximum drawdown of -49.92%. Use the drawdown chart below to compare losses from any high point for CORT and AMPH. For additional features, visit the drawdowns tool.
Volatility
CORT vs. AMPH - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) and Amphastar Pharmaceuticals, Inc. (AMPH) have volatilities of 8.55% and 8.86%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CORT vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities